JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

Search

Simulations Plus Inc

Затворен

СекторЗдравеопазване

17.59 14.07

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

16.22

Максимум

18.11

Ключови измерители

By Trading Economics

Приходи

-70M

-67M

Продажби

-2.1M

20M

P/E

Средно за сектора

48.528

37.461

Дивидентна доходност

0.48

Марж на печалбата

-330.585

Служители

243

EBITDA

-79M

-74M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+2.83% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.48%

2.33%

Следващи печалби

29.10.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-28M

323M

Предишно отваряне

3.52

Предишно затваряне

17.59

Настроения в новините

By Acuity

38%

62%

133 / 371 Класиране в Healthcare

Simulations Plus Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

22.10.2025 г., 22:47 ч. UTC

Придобивния, сливания и поглъщания

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

22.10.2025 г., 22:13 ч. UTC

Придобивния, сливания и поглъщания

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

22.10.2025 г., 21:20 ч. UTC

Печалби

Correction to IBM 3Q Sales Jump Article

22.10.2025 г., 20:57 ч. UTC

Печалби

SAP Posts Higher 3Q Revenue, Operating Profit

22.10.2025 г., 23:46 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

22.10.2025 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

22.10.2025 г., 23:41 ч. UTC

Пазарно говорене

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22.10.2025 г., 23:38 ч. UTC

Пазарно говорене

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22.10.2025 г., 23:15 ч. UTC

Печалби

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

22.10.2025 г., 22:28 ч. UTC

Пазарно говорене

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

22.10.2025 г., 22:02 ч. UTC

Печалби

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

22.10.2025 г., 21:59 ч. UTC

Придобивния, сливания и поглъщания

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

22.10.2025 г., 21:58 ч. UTC

Придобивния, сливания и поглъщания

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

22.10.2025 г., 21:57 ч. UTC

Придобивния, сливания и поглъщания

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

22.10.2025 г., 21:56 ч. UTC

Придобивния, сливания и поглъщания

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

22.10.2025 г., 21:47 ч. UTC

Придобивния, сливания и поглъщания

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

22.10.2025 г., 21:47 ч. UTC

Печалби

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22.10.2025 г., 21:47 ч. UTC

Придобивния, сливания и поглъщания

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

22.10.2025 г., 21:46 ч. UTC

Придобивния, сливания и поглъщания

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

22.10.2025 г., 21:45 ч. UTC

Придобивния, сливания и поглъщания

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

22.10.2025 г., 21:45 ч. UTC

Придобивния, сливания и поглъщания

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

22.10.2025 г., 21:28 ч. UTC

Пазарно говорене
Печалби

Correction to Alcoa Tariff Market Talk

22.10.2025 г., 21:25 ч. UTC

Печалби

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

22.10.2025 г., 21:17 ч. UTC

Печалби

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

22.10.2025 г., 21:09 ч. UTC

Пазарно говорене
Печалби

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

22.10.2025 г., 21:00 ч. UTC

Пазарно говорене

ESG Roundup: Market Talk

22.10.2025 г., 20:59 ч. UTC

Печалби

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22.10.2025 г., 20:51 ч. UTC

Печалби

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

22.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

22.10.2025 г., 20:44 ч. UTC

Печалби

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Сравнение с други в отрасъла

Ценова промяна

Simulations Plus Inc Прогноза

Ценова цел

By TipRanks

2.83% нагоре

12-месечна прогноза

Среден 16 USD  2.83%

Висок 16 USD

Нисък 16 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Simulations Plus Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

3 ratings

1

Купи

2

Задържане

0

Продай

Настроение

By Acuity

133 / 371 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat